tiprankstipranks
Processa Pharmaceuticals (PCSA)
NASDAQ:PCSA
US Market

Processa Pharmaceuticals (PCSA) Income Statement

Compare
153 Followers

Processa Pharmaceuticals Income Statement

Last quarter (Q3 2024), Processa Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Processa Pharmaceuticals's net income was $-3.38M. See Processa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -222.00$ -27.53M$ -12.13M$ -15.14M$ -877.90K
Operating Expenses
$ 11.46M$ 20.26M$ 11.57M$ 6.44M$ 3.94M
Depreciation and Amortization
$ 222.00$ 874.01K$ 875.35K$ 882.06K$ 877.90K
EBITDA
$ -11.46M$ -19.47M$ -11.08M$ -5.63M$ -3.05M
Operating Income
$ -11.46M$ -27.53M$ -12.13M$ -15.14M$ -3.94M
Other Income/Expenses
$ 335.54K$ 101.20K$ 175.40K$ -277.95K$ -25.11K
Pretax Income
$ -11.12M$ -27.42M$ -11.96M$ -15.41M$ -3.96M
Net Income
$ -11.12M$ -54.85M$ -11.43M$ -14.41M$ -3.36M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -8.48$ -68.00$ -15.00$ -38.40$ -12.17
Diluted EPS
$ -8.48$ -68.00$ -15.00$ -38.40$ -12.17
Weighted Average Shares Outstanding
1.31M 805.46K 765.97K 374.98K 275.87K
Weighted Average Shares Outstanding (Diluted)
1.31M 805.46K 765.97K 374.98K 275.87K
Currency in USD

Processa Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis